| 摘要 |
The invention relates to medicine, in particular to infectious diseases and can be used for the treatment of enteroviral meningitis in children.According to the invention, the claimed method consists in that it is performed the basic therapy, comprising compliance with hygiene regimen, diet, bed rest in the acute period, pathogenetic, symptomatic, detoxification and cerebral circulation improving treatment, at the same time additionally per os is administered 5α-furostan-3β,22,26-triol-3-[O-β-D-glucopyranosyl-(1→2)-β-D- glucopyranosyl(1→4)-β-D-galactopyranosyl]-26-O-β-D-glucopyranoside), 100 mg 2 times a day, 30 minutes before meal, for 30 days. |
